New chagas drug candidate passes first safety test in small trial
Disease control
Completed
This early-phase trial tested the safety of an experimental drug called ICM20 in 13 adults with Chagas disease who had not been treated before. Participants took ICM20 along with the standard drug benznidazole. The main goal was to check for side effects and see how many people s…
Phase: PHASE1 • Sponsor: IC-MedTech Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC